Trial Profile
Phase II study of S-1 plus Leucovorin for metastatic pancreatic adenocarcinoma (JASPAC 03).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Folinic acid (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Adenosquamous carcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 13 May 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 15 Feb 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 28 Jan 2011 New trial record